303 related articles for article (PubMed ID: 18549626)
41. Clinical characteristics and prognostic analysis of primary extranodal non-Hodgkin lymphoma of the head and neck.
Lv J; Jiang Y; Yu T; Gao S; Yin W
Aging (Albany NY); 2024 Apr; 16(8):6796-6808. PubMed ID: 38604163
[TBL] [Abstract][Full Text] [Related]
42. [Clinical characteristics and treatment outcome of 36 cases with non-Hodgkin's lymphoma arising from mediastinum in children].
Tang YJ; Tang JY; Pan C; Xue HL; Chen J; Shen SH; Dong L; Zhou M; Wang YP; Gu LJ; Jiang H; Ye QD
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):687-90. PubMed ID: 20021793
[TBL] [Abstract][Full Text] [Related]
43. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
44. Bone marrow and peripheral blood changes in non-Hodgkin's lymphoma.
Lim EJ; Peh SC
Singapore Med J; 2000 Jun; 41(6):279-85. PubMed ID: 11109344
[TBL] [Abstract][Full Text] [Related]
45. [Incidence and histologic patterns of bone marrow involvement of malignant lymphoma based on the World Health Organization classification: a single institution study].
Jeong SY; Chang YH; Lee JK; Hong YJ; Hong SI; Lee SS
Korean J Lab Med; 2007 Dec; 27(6):383-7. PubMed ID: 18160826
[TBL] [Abstract][Full Text] [Related]
46. [Clinicopathological features and prognostic analysis of 151 patients with primary extra-nodal non-Hodgkin's lymphoma].
Wang C; Yuan C; He H; Bai O
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):858-62. PubMed ID: 25620485
[TBL] [Abstract][Full Text] [Related]
47. Polo-like kinase 1 as a new target for non-Hodgkin's lymphoma treatment.
Liu L; Zhang M; Zou P
Oncology; 2008; 74(1-2):96-103. PubMed ID: 18547964
[TBL] [Abstract][Full Text] [Related]
48. [BCL-2/IgH and IgH gene rearrangements in bone marrow mononuclear cells of patients with non-Hodgkin's lymphoma].
Zhang XH; Liang Y; Wang GJ; Ruan EB; Fu R; Qu W; Liu H; Guan J; Song J; Wang HQ; Wu YH; Xing LM; Wang XM; Wang J; Li LJ; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):379-84. PubMed ID: 21518492
[TBL] [Abstract][Full Text] [Related]
49. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
Vaccher E; Tirelli U; Spina M; Talamini R; Errante D; Simonelli C; Carbone A
J Clin Oncol; 1996 Aug; 14(8):2217-23. PubMed ID: 8708710
[TBL] [Abstract][Full Text] [Related]
50. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
[TBL] [Abstract][Full Text] [Related]
51. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
52. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
53. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
54. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
[TBL] [Abstract][Full Text] [Related]
55. [Prognostic factors in patients with primary non-Hodgkin's lymphoma of the tonsil].
Gao Y; Li Y; Yuan Z; Zhao L; Liu X; Gu D; Qian T; Yu Z
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):483-5. PubMed ID: 12485504
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.
Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN
Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954
[TBL] [Abstract][Full Text] [Related]
57. [Application of multiparameter flow cytometry in diagnosis of non-Hodgkin lymphoma].
He FJ; Xie Y; Li JY; Yong WB; Lu AP; Zhu J
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):203-8. PubMed ID: 16776976
[TBL] [Abstract][Full Text] [Related]
58. Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsets.
Leith CP; Spier CM; Grogan TM; Gonzales G; Rangel CS; Rybski JA; Matzner M; Miller TP
J Clin Oncol; 1992 Aug; 10(8):1259-65. PubMed ID: 1634915
[TBL] [Abstract][Full Text] [Related]
59. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].
Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ
Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885
[TBL] [Abstract][Full Text] [Related]
60. Cost determinants in aggressive non-Hodgkin's lymphoma.
van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
